<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter>David R. Raleigh</submitter><journal>The Journal of Cell Biology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-JCBD-201010065</full_dataset_link><attach_to>JCB</attach_to><legend>Image stack showing EGFP-occludin S408A (green) and ZO-1 (red) in TBCA-treated Caco-2 monolayers.</legend><legend>Image stack of endogenous occludin (green) and ZO-1 (red) in DMAT-treated Caco-2 monolayers.</legend><legend>Image stack showing EGFP-occludin S408D (green) and ZO-1 (red) in TBCA-treated Caco-2 monolayers.</legend><legend>Image stack showing EGFP-occludin (green) and ZO-1 (red) in control- (vehicle-) treated Caco-2 monolayers.</legend><legend>Image stack showing CK2 (green) and ZO-1 (red) in TBCA-treated Caco-2 monolayers.</legend><legend>Image stack showing EGFP-occludin S408D (green) and ZO-1 (red) in control- (vehicle-) treated Caco-2 monolayers.</legend><legend>Image stack of endogenous occludin (green) and ZO-1 (red) in control- (vehicle-) treated Caco-2 monolayers.</legend><legend>Image stack showing CK2 (green) and ZO-1 (red) in control- (vehicle-) treated Caco-2 monolayers.</legend><legend>Image stack showing EGFP-occludin S408A (green) and ZO-1 (red) in control- (vehicle-) treated Caco-2 monolayers</legend><legend>Image stack showing EGFP-occludin (green) and ZO-1 (red) in TBCA-treated Caco-2 monolayers.</legend><repository>bioimages</repository><figure_sub>Image 32460 (Supplemental Figure 3 - A)</figure_sub><figure_sub>Supplemental Figure 1 - F</figure_sub><figure_sub>Supplemental Figure 3 - A</figure_sub><figure_sub>Image 32456 (Figure 2 - A)</figure_sub><figure_sub>Supplemental Figure 3</figure_sub><figure_sub>Image 32462 (Supplemental Figure 3 - A)</figure_sub><figure_sub>Supplemental Figure 1</figure_sub><figure_sub>Image 32453 (Supplemental Figure 1 - F)</figure_sub><figure_sub>Image 32458 (Supplemental Figure 3 - A)</figure_sub><figure_sub>Image 32461 (Supplemental Figure 3 - A)</figure_sub><figure_sub>Image 32459 (Supplemental Figure 3 - A)</figure_sub><figure_sub>Image 32455 (Figure 2 - A)</figure_sub><figure_sub>Figure 2 - A</figure_sub><figure_sub>Image 32457 (Supplemental Figure 3 - A)</figure_sub><figure_sub>Figure 2</figure_sub><figure_sub>Image 32454 (Supplemental Figure 1 - F)</figure_sub><pubmed_authors>Emily M. Bradford</pubmed_authors><pubmed_authors>Licheng Wu</pubmed_authors><pubmed_authors>Jerrold R. Turner</pubmed_authors><pubmed_authors>Devin M. Boe</pubmed_authors><pubmed_authors>Christopher R. Weber</pubmed_authors><pubmed_authors>Le Shen</pubmed_authors><pubmed_authors>Dan Yu</pubmed_authors><pubmed_authors>Amanda M. Marchiando</pubmed_authors><pubmed_authors>Yingmin Wang</pubmed_authors><pubmed_authors>David R. Raleigh</pubmed_authors><pubmed_authors>Eveline E. Schneeberger</pubmed_authors></additional><is_claimable>false</is_claimable><name>Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function</name><description/><dates><release>2011-05-02T11:21:23Z</release><modification>2018-11-29T11:21:23Z</modification><creation>2018-11-29T11:21:23Z</creation></dates><accession>S-JCBD-201010065</accession><cross_references><doi>10.1083/jcb.201010065</doi></cross_references></HashMap>